Top compounds associated with response to RP11-226E21.4


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.021 0.6
mRNA BRD-A02303741 CTRPv2 pan-cancer AAC -0.024 0.6
mRNA niclosamide CTRPv2 pan-cancer AAC -0.022 0.6
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.02 0.6
mRNA Mdivi-1 CTRPv2 pan-cancer AAC -0.022 0.6
mRNA BRD-K78574327 CTRPv2 pan-cancer AAC 0.043 0.6
mRNA BRD-K27986637 CTRPv2 pan-cancer AAC -0.042 0.6
mRNA MLN4924 CTRPv2 pan-cancer AAC -0.02 0.6
mRNA SNX-2112 CTRPv2 pan-cancer AAC 0.019 0.6
mRNA CHEMBL374350 CTRPv2 pan-cancer AAC 0.022 0.6
Download CSV